Morocco's Laprophan initial public offering drew 15.3 billion dirhams ($1.5 billion) in orders, making it seven times oversubscribed on the Casablanca Stock Exchange. The listing is the largest on the local bourse this year, combining new and existing shares. The transaction highlights strong investor appetite for pharmaceutical assets in the North African market.
Laprophan IPO Oversubscribed Seven Times
Moroccan pharmaceutical company Laprophan saw its initial public offering oversubscribed seven times as investors submitted orders worth 15.3 billion dirhams. The Casablanca Stock Exchange listing aims to fund expansion plans.







